Protective Function of STAT3 in CVB3-Induced Myocarditis

Diana Lindner1, Moritz Hilbrandt, Katharina Marggraf

  • 1Department of Cardiology and Pneumology, Charité-Universitäts-Medizin Berlin, Campus Benjamin Franklin, 12200 Berlin, Germany.

Insights

Signal transducer and activator of transcription 3 (STAT3) protects the heart during viral myocarditis. STAT3 deficiency in cardiomyocytes increases cardiac fibrosis and impairs function after Coxsackievirus B3 infection.

Area of Science:

  • Cardiovascular Research
  • Immunology
  • Virology

Background:

  • Signal transducer and activator of transcription 3 (STAT3) is a key mediator in inflammatory processes.
  • Viral myocarditis can progress to dilated cardiomyopathy.
  • The specific role of STAT3 in cardiomyocyte-mediated inflammation and fibrosis is not fully understood.

Purpose of the Study:

  • To investigate the role of STAT3 in viral myocarditis induced by Coxsackievirus B3 (CVB3).
  • To determine if STAT3 deficiency in cardiomyocytes contributes to the development of dilated cardiomyopathy.
  • To elucidate the protective mechanisms of STAT3 signaling in the heart during viral infection.

Main Methods:

  • Utilized STAT3-deficient mice with cardiomyocyte-restricted knockout (STAT3 KO).
  • Induced viral myocarditis using Coxsackievirus B3 (CVB3) infection.
  • Assessed viral clearance, inflammation, cardiac function, collagen I expression, and matrix degradation at 4 weeks post-infection.

Main Results:

  • STAT3 KO mice exhibited severe inflammation during the acute phase of CVB3 infection.
  • While virus clearance and inflammation were attenuated by 4 weeks in both groups, STAT3 KO mice showed significantly decreased cardiac function.
  • Increased collagen I expression and reduced matrix degradation were observed in STAT3 KO mice, indicating enhanced fibrosis.

Conclusions:

  • STAT3 signaling in cardiomyocytes plays a protective role against CVB3-induced myocarditis.
  • Cardiomyocyte-specific STAT3 deficiency leads to increased cardiac fibrosis, suggesting a protective function through paracrine effects.
  • STAT3 signaling is crucial for maintaining cardiac function and preventing excessive fibrosis during viral myocarditis.

Related Concept Videos

Myocarditis III: Medical Management01:14

Myocarditis III: Medical Management

Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
Myocarditis II: Clinical Features and Diagnostic Tests01:27

Myocarditis II: Clinical Features and Diagnostic Tests

Myocarditis is an inflammation of the heart muscle. The symptoms vary widely, encompassing asymptomatic presentations to severe, acute manifestations.Clinical PresentationAsymptomatic cases: In some instances, myocarditis may be asymptomatic, with the infection resolving without intervention. These cases often go undetected unless discovered incidentally through diagnostic imaging or tests conducted for other reasons.General Early Symptoms: Early symptoms of myocarditis are non-specific and can...
Myocarditis I: Introduction01:21

Myocarditis I: Introduction

Myocarditis is inflammation of the myocardium, which is the muscular layer of the heart.EtiologyMyocarditis has a diverse etiology, including a wide range of infectious and non-infectious causes:Infectious CausesViral: Common viruses include Coxsackie A and B, adenovirus, parvovirus B19, enteroviruses, and influenza A.Bacterial: Examples include infections caused by Streptococcus, Staphylococcus, and Mycoplasma species.Rickettsial: Infections like Rocky Mountain spotted fever can result in...
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...